Vitamin D Deficiency Increases Pneumonia & Bronchitis Hospitalization Risk

MADRID,22 Ene. (EUROPA PRESS) –

La vitamina D es una sustancia‍ esencial para el organismo que ayuda a mantener los huesos y músculos fuertes, y también contribuye al buen funcionamiento del sistema inmunitario. Se obtiene principalmente⁤ a través de la exposición al sol, pero también está presente en alimentos como el pescado graso, los huevos y productos fortificados, y puede completarse mediante suplementos cuando no se alcanzan los niveles recomendados.

La neumonía y la bronquitis son infecciones respiratorias que afectan a⁤ los pulmones y a las ⁢vías respiratorias. La bronquitis se produce cuando los bronquios se inflaman, causando tos y dificultad para respirar, mientras que la neumonía es una infección más⁢ grave que inflama los ⁤alvéolos pulmonares y puede requerir hospitalización. Ambas condiciones son más comunes en personas mayores y en quienes tienen defensas bajas.

La deficiencia grave de vitamina D se asocia⁢ con una ⁣mayor tasa de hospitalización por infecciones de las vías respiratorias, como bronquitis y neumonía, según un nuevo estudio dirigido por la Universidad de Surrey (Reino Unido). Los científicos descubrieron que quienes presentaban una deficiencia grave (menos de 15 nmol/L) tenían un ‍33% más de probabilidades de ser hospitalizados para recibir tratamiento que quienes tenían niveles suficientes de vitamina D (al menos 75 nmol/L).

Los resultados se publican en ‘American Journal of Clinical Nutrition’.

En el estudio más amplio de su tipo, que analiza datos del NHS del Biobanco del Reino Unido, investigadores de Surrey, en colaboraci

PHASE 1:⁢ ADVERSARIAL RESEARCH, FRESHNESS &⁢ BREAKING-NEWS CHECK – vitamin D & Respiratory Infections

Here’s a breakdown of verifying the claims in the provided text, checking for contradicting ‍details, ⁤and a breaking news assessment.

1. Factual Claim Verification & Contradiction Search:

* claim‍ 1: Vitamin D is vital for physical wellbeing, bone & muscle health, and perhaps reduces risk of respiratory infections.

⁤ * Verification: This is largely supported by established scientific consensus. The National Institutes of Health (NIH) confirms Vitamin D’s role in bone ⁤health and immune function (https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/). The link to immune⁣ function and reduced respiratory ⁤infection risk is an area of ongoing research,‍ but plausible.
⁤ ‍ * Contradiction/Nuance: The relationship isn’t ⁤simple causation. ⁤Many studies show correlation, not ⁤necessarily that Vitamin D prevents infection, but may reduce severity. ‍Over-supplementation ⁤can also be harmful.
* Claim 2: Many people are deficient in Vitamin D and don’t reach⁢ the recommended 10 micrograms/day.

* Verification: ⁤This is generally true, particularly in regions with limited sunlight. Studies ⁢consistently ‍show widespread Vitamin D deficiency, especially in winter months and among certain populations (older adults, people with darker⁤ skin).The 10 microgram recommendation is ‍consistent with UK guidelines (https://www.nhs.uk/conditions/vitamins-and-minerals/vitamin-d/).
⁣ * Contradiction/Nuance: “Many” ‍is vague. ⁣ Deficiency rates vary significantly by location, season, and population group.
* Claim ⁣3: severe Vitamin D deficiency (<15 nmol/L) is associated with a 33% higher hospitalization rate for respiratory infection compared to levels >=75 nmol/L.

* Verification: This is the moast critical claim and⁣ requires⁢ careful scrutiny.⁢ While ⁣several studies suggest a link between low⁤ Vitamin D and increased respiratory infection risk, a 33% increase specifically tied to those thresholds is a strong statement. A meta-analysis ‍published in The Lancet (2017) showed a modest association, but not as definitive as 33% (https://www.thelancet.com/journals/landia/article/PIIS2213-8587(17)30047-8/fulltext30047-8/fulltext)). The specific 15 nmol/L and 75 nmol/L cutoffs are also crucial to verify within the context of the Biobank study methodology.
* Contradiction/Nuance: This is where the “untrusted source” warning is crucial. The study’s methodology (Biobank data analysis) needs to be examined for potential biases. ‍ Correlation does not equal causation. Other factors (age, comorbidities, socioeconomic status) could be ‍confounding variables.
* Claim 4: For every 10 nmol/L increase in Vitamin D, hospitalization rates for respiratory infections decrease by 4%.

⁤ * Verification: Similar to the previous claim, this is a specific quantitative statement ⁤requiring verification from the original Biobank study. The Lancet meta-analysis showed a smaller,less precise effect.
* Contradiction/Nuance: ‍the linear relationship implied (4% decrease per 10 nmol/L) may not be accurate. The effect might plateau at higher Vitamin D levels.
* Claim 5: Infections of the respiratory tract pose a significant global health ⁤threat.

* Verification: Undisputed.Respiratory infections (influenza,pneumonia,COVID-19,etc.) are‍ a leading cause of morbidity and mortality worldwide (WHO data: https://www.who.int/news-room/fact-sheets/detail/influenza).

2. Breaking news Check (as of October 26, 2023):

* Recent‍ Research: There’s ongoing research into Vitamin D and⁤ COVID-19, but the results are mixed. Early in the pandemic, there was significant interest, but more recent studies haven’t shown a strong ‍protective effect against infection. Research continues on Vitamin D’s role in⁢ *